CoChat

Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells

Open access
Yi, Yu, Kim, Hyun Jin, Zheng, Meng, Mi, Peng, Naito, Mitsuru, Kim, Beob Soo, Min, Hyun Su, Hayashi, Kotaro, Perche, Federico, Toh, Kazuko, Liu, Xueying, Mochida, Yuki, Kinoh, Hiroaki, Cabral, Horacio, Miyata, Kanjiro, Kataoka, Kazunori · 2019 · Journal of Controlled Release
Cited by 127

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Abstract Cancer stem‐like cells (CSCs) treatment is a plausible strategy for enhanced cancer therapy. Here we report a glucose‐installed sub‐50‐nm nanocarrier for the targeted delivery of small interfering RNA (siRNA) to CSCs through selective recognition of the glucose ligand to the glucose transporter 1 (GLUT1) overexpressed on the CSC surface. The siRNA nanocarrier was constructed via a two‐step assembling process. First, a glucose‐installed poly(ethylene glycol)‐block‐poly(l‐lysine) modified with lipoic acid (LA) at the ω‐end (Glu‐PEG‐PLL‐LA) was associated with a single siRNA to form a unimer polyion complex (uPIC). Second, a 20 nm gold nanoparticle (AuNP) was decorated with ˜65 uPICs through Au‐S bonding. The glucose‐installed targeted nanoparticles (Glu‐NPs) exhibited higher cellular uptake of siRNA payloads in a spheroid breast cancer (MBA‐MB‐231) cell culture compared with glucose‐unconjugated control nanoparticles (MeO‐NPs). Notably, the Glu‐NPs became more efficiently internalized into the CSC fraction, which was defined by aldehyde dehydrogenase (ALDH) activity assay, than the other fractions, probably due to the higher GLUT1 expression level on the CSCs. The Glu‐NPs elicited significantly enhanced gene silencing in a CSC‐rich orthotopic MDA‐MB‐231 tumor tissue following systemic administration to tumor‐bearing mice. Ultimately, the repeated administrations of polo‐like kinase 1 (PLK1) siRNA‐loaded Glu‐NPs significantly suppressed the growth of orthotopic MDA‐MB‐231 tumors. These results demonstrate that Glu‐NP is a promising nanocarrier design for CSC‐targeted cancer treatment. Graphical abstract Figure. No Caption available. HighlightsGlucose‐installed nanoparticle (Glu‐NP) was made for cancer stem cell‐targeted siRNA delivery.Glu‐NP was made by conjugating unimer polyion complexes on Au nanoparticle.Enhanced cellular uptake of Glu‐NP was observed in cancer stem cells in spheroid culture.Glu‐NP loaded with PLK1 siRNA suppressed growth of orthotopic breast tumor model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2019.01.006

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

Metadata

Authors
Yi, Y., Kim, H. J., Zheng, M., Mi, P., Naito, M., Kim, B. S., Min, H. S., Hayashi, K., Perche, F., Toh, K., Liu, X., Mochida, Y., Kinoh, H., Cabral, H., Miyata, K., & Kataoka, K.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2019-02
Volume
295
Pages
268-277
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2910706037
Cited by
127
References
11
FWCI
4.73
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.